BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9621387)

  • 1. Increased nuchal translucency and CATCH 22.
    Lazanakis MS; Rodgers K; Economides DL
    Prenat Diagn; 1998 May; 18(5):507-10. PubMed ID: 9621387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of 22q11 microdeletion in an early second-trimester fetus with conotruncal anomaly presenting with increased nuchal translucency and bilateral intracardiac echogenic foci.
    Machlitt A; Tennstedt C; Körner H; Bommer C; Chaoui R
    Ultrasound Obstet Gynecol; 2002 May; 19(5):510-3. PubMed ID: 11982988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for 22q11 microdeletion in 146 fetuses with nuchal translucency above the 99th percentile and a normal karyotype.
    Lautrup CK; Kjaergaard S; Brøndum-Nielsen K; Fagerberg C; Hertz JM; Petersen OB; Jørgensen MW; Vogel I
    Acta Obstet Gynecol Scand; 2008; 87(11):1252-5. PubMed ID: 18951212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency.
    Hollis B; Mavrides E; Carvalho JS; Hill L; Dickinson V; Thilaganathan B
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):32-4. PubMed ID: 11489222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
    Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
    J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of 22q11 deletion analysis in fetuses with excess nuchal translucency.
    Donnenfeld AE; Cutillo D; Horwitz J; Knops J
    Am J Obstet Gynecol; 2006 Feb; 194(2):508-11. PubMed ID: 16458654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DiGeorge syndrome: part of CATCH 22.
    Wilson DI; Burn J; Scambler P; Goodship J
    J Med Genet; 1993 Oct; 30(10):852-6. PubMed ID: 8230162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of 22q11 microdeletion in a fetus with a conotruncal heart defect.
    Paladini D; Pacileo G; Palmieri S; Russo MG; Conti A; Piccola BD; Martinelli P
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):68-70. PubMed ID: 9511201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2].
    Trost D; Engels H; Bauriedel G; Wiebe W; Schwanitz G
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):3-7. PubMed ID: 9951451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations.
    Alikaşifoğlu M; Malkoç N; Ceviz N; Ozme S; Uludoğan S; Tunçbilek E
    Turk J Pediatr; 2000; 42(3):215-8. PubMed ID: 11105620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.
    Schindewolf E; Khalek N; Johnson MP; Gebb J; Coleman B; Crowley TB; Zackai EH; McDonald-McGinn DM; Moldenhauer JS
    Am J Med Genet A; 2018 Aug; 176(8):1735-1741. PubMed ID: 30055034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and Postnatal Diagnosis of 10p14 Deletion and 22q11.2 Deletion Syndrome and Significance of Non-Cardiac Markers.
    Shetty M; Srikanth A; Kadandale J; Hegde S
    Cytogenet Genome Res; 2016; 148(4):249-55. PubMed ID: 27300488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DiGeorge syndrome with microdeletion of chromosome 22q11.2: report of one case.
    Wang JL; Chen SJ; Chung MY; Niu DM; Lin CY; Hwang BT; Lu JH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(5):385-9. PubMed ID: 9401184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
    Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
    Am J Med Genet; 1994 Oct; 52(4):445-9. PubMed ID: 7747757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuchal translucency and congenital heart defects: heart failure or not?
    Simpson JM; Sharland GK
    Ultrasound Obstet Gynecol; 2000 Jul; 16(1):30-6. PubMed ID: 11084962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [22q11.2 deletion syndrome and complex congenital heart defects].
    Rosa RF; Trevisan P; Koshiyama DB; Pilla CB; Zen PR; Varella-Garcia M; Paskulin GA
    Rev Assoc Med Bras (1992); 2011; 57(1):62-5. PubMed ID: 21390462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
    Jemmali M; Valat AS; Poulain P; Favre R; Bourgeot P; Subtil D; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):538-43. PubMed ID: 10598347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.